Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth M Jaffee

Showing results (31-40 of 291) with videos related to

Pageof 30
Sort By:
Seminars in Oncology|December 3, 2014
Specificity delivers: therapeutic role of tumor antigen-specific antibodies in pancreatic cancerDarshil T Jhaveri, Lei Zheng, Elizabeth M Jaffee
Lancet (London, England)|February 24, 2009
Use of tumour-responsive T cells as cancer treatmentMary L Disis, Helga Bernhard, Elizabeth M Jaffee
Molecular Cancer Therapeutics|November 9, 2005
Genes to vaccines for immunotherapy: how the molecular biology revolution has influenced cancer immunologyDan A Laheru, Drew M Pardoll, Elizabeth M Jaffee
Cancer Journal (Sudbury, Mass.)|August 10, 2010
Cellular vaccine approachesDung T Le, Drew M Pardoll, Elizabeth M Jaffee
Trends in Cell Biology|February 11, 2022
Shared genetic and epigenetic changes link aging and cancerDaniel J Zabransky, Elizabeth M Jaffee, Ashani T Weeraratna
The Lancet. Oncology|January 22, 2021
Cancer Moonshot 2.0David B Agus, Elizabeth M Jaffee, Chi Van Dang
Gastroenterology|April 30, 2013
Role of immune cells and immune-based therapies in pancreatitis and pancreatic ductal adenocarcinomaLei Zheng, Jing Xue, Elizabeth M Jaffee, et al.
Cancer Treatment and Research|October 11, 2005
Cancer vaccines in combination with multimodality therapyLeisha A Emens, R Todd Reilly, Elizabeth M Jaffee
Breast Disease|February 3, 2005
Augmenting the potency of breast cancer vaccines: combined modality immunotherapyLeisha A Emens, R Todd Reilly, Elizabeth M Jaffee
Cancer Immunology Research|April 26, 2014
Apoptosis-regulated low-avidity cancer-specific CD8(+) T cells can be rescued to eliminate HER2/neu-expressing tumors by costimulatory agonists in tolerized miceChelsea M Black, Todd D Armstrong, Elizabeth M Jaffee
Pageof 30

Showing results (31-40 of 291) with videos related to

Sort By:
Pageof 30
Seminars in Oncology|December 3, 2014
Specificity delivers: therapeutic role of tumor antigen-specific antibodies in pancreatic cancerDarshil T Jhaveri, Lei Zheng, Elizabeth M Jaffee
Lancet (London, England)|February 24, 2009
Use of tumour-responsive T cells as cancer treatmentMary L Disis, Helga Bernhard, Elizabeth M Jaffee
Molecular Cancer Therapeutics|November 9, 2005
Genes to vaccines for immunotherapy: how the molecular biology revolution has influenced cancer immunologyDan A Laheru, Drew M Pardoll, Elizabeth M Jaffee
Cancer Journal (Sudbury, Mass.)|August 10, 2010
Cellular vaccine approachesDung T Le, Drew M Pardoll, Elizabeth M Jaffee
Trends in Cell Biology|February 11, 2022
Shared genetic and epigenetic changes link aging and cancerDaniel J Zabransky, Elizabeth M Jaffee, Ashani T Weeraratna
The Lancet. Oncology|January 22, 2021
Cancer Moonshot 2.0David B Agus, Elizabeth M Jaffee, Chi Van Dang
Gastroenterology|April 30, 2013
Role of immune cells and immune-based therapies in pancreatitis and pancreatic ductal adenocarcinomaLei Zheng, Jing Xue, Elizabeth M Jaffee, et al.
Cancer Treatment and Research|October 11, 2005
Cancer vaccines in combination with multimodality therapyLeisha A Emens, R Todd Reilly, Elizabeth M Jaffee
Breast Disease|February 3, 2005
Augmenting the potency of breast cancer vaccines: combined modality immunotherapyLeisha A Emens, R Todd Reilly, Elizabeth M Jaffee
Cancer Immunology Research|April 26, 2014
Apoptosis-regulated low-avidity cancer-specific CD8(+) T cells can be rescued to eliminate HER2/neu-expressing tumors by costimulatory agonists in tolerized miceChelsea M Black, Todd D Armstrong, Elizabeth M Jaffee
Pageof 30